retatrutide clinical trials us Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial Retatrutide Results: 28.3% Weight Loss
Description
doi: 10.1111/dom.13764
Changes in Gum Health Dry mouth, changes in hydration, and shifts in eating habits may contribute to gum irritation or sensitivity in some patients
Common concentrations include 1 mg/mL, 2 mg/mL, 2.5 mg/mL, 3 mg/mL, 5 mg/mL, and 10 mg/mL
www.medscape.com
Meal timing: Smaller, more frequent meals help some people handle GI effects during early titration
That's why fitter individuals show smaller increases in HR
